yup. It gapped down at the open. blew by 58 and landed on 39. It will drift back above 40 after the next earnings report. Of course he can now buy all his stock back at 33 that he sold at 39.... so not bad.18% more shares.
Somebody was pulling Pops' leg when the potential for 5461 got exagerated. But
I do not think 26 points on the shareprice represented the value of this stage 3 study.
Buying opportunity... this will recover 15 points by the end of May.
we are just beginning to see what Viv will do to the revenue side of things.
I would call today's action a down day. A bonafide selloff requires convincing volume across the board.
This is more like a designed swing.
28, yes. Fund technicians will be looking for equities with improved earnings.
I say it breeches 40 by dec 31.
HZNP reminds me of Alkermes just before it rose out of the teens three years ago. Always good earnings reports and increasing revenue. But in the weeks before the reporting day, the manipulation guys would whipsaw the trading trying to make one think that a negative surprise was in the cards.
Then it took off, trading in 60's today.
3-4 weeks till earnings.
Thanks for keeping it smart here.
Made my first purchase this morning. I was expecting another catenary curve on the daily chart so I bought at 10am thinking it would rise to higher close.
got home from work, whamo.
I thought pharms that perform were supposed to be flight to safety stocks.
maybe some deep in the money calls for May are in order. That will be after two more earnings reports.
The people who own the computers own the markets, for now.